{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:59:32Z","timestamp":1788490772488,"version":"build-2803163510"},"reference-count":272,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cardiovascular diseases (CVDs) remain the leading global cause of disability and mortality, with chronic immune inflammation as their central pathological mechanism. Regulatory T cells (Tregs) and the peripheral immune tolerance they mediate hold a pivotal position and therapeutic potential in CVDs. This review provides a comprehensive overview of Tregs biology, their dysfunction in major CVDs, current therapeutic strategies targeting Tregs, and future directions for achieving immune homeostasis. By moving beyond the traditional focus on numerical deficiency, we highlight the critical role of functional heterogeneity and cellular dysfunction in CVDs pathogenesis, and discuss the emerging therapeutic concept of moving from delaying disease progression to restoring immune homeostasis.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1776040","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:19:05Z","timestamp":1774502345000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Regulatory T cells and peripheral immune tolerance: key mechanisms and therapeutic strategies for cardiovascular diseases"],"prefix":"10.3389","volume":"17","author":[{"given":"Mengna","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Cardiac Surgery, Lanzhou University Second Hospital, Lanzhou University","place":["Lanzhou, China"]},{"name":"Second Clinical Medical College, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Lanzhou University Second Hospital, Lanzhou University","place":["Lanzhou, China"]},{"name":"Second Clinical Medical College, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Lanzhou University Second Hospital, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Lanzhou University Second Hospital, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongnan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Lanzhou University Second Hospital, Lanzhou University","place":["Lanzhou, China"]},{"name":"Second Clinical Medical College, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Lanzhou University Second Hospital, Lanzhou University","place":["Lanzhou, China"]},{"name":"Second Clinical Medical College, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"B1","volume-title":"StatPearls","author":"Olvera Lopez","year":"2023"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/mbp.0b013e3283624b24","article-title":"Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure, and mortality: A cohort study","volume":"163","author":"Muntner","year":"2015","journal-title":"Ann Internal Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-3-319-57613-8_10","article-title":"Cardiac autoimmunity: myocarditis","volume":"1003","author":"Bracamonte-Baran","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05432-3","article-title":"T cells specific for \u03b1-myosin drive immunotherapy-related myocarditis","volume":"611","author":"Axelrod","year":"2022","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0590-4","article-title":"Single-cell immune landscape of human atherosclerotic plaques","volume":"25","author":"Fernandez","year":"2019","journal-title":"Nat Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.02.012","article-title":"Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses","volume":"40","author":"Joller","year":"2014","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"B8","article-title":"Cell interactions in the induction of tolerance: The role of thymic lymphocytes","volume":"18","author":"Gershon","year":"1970","journal-title":"Immunology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065x.1975.tb00179.x","article-title":"A disquisition on suppressor T cells","volume":"26","author":"Gershon","year":"1975","journal-title":"Transplant Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.2.387","article-title":"Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation","volume":"184","author":"Asano","year":"1996","journal-title":"J Exp Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.9.5317","article-title":"Thymus and autoimmunity: Production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance","volume":"162","author":"Itoh","year":"1999","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nature05563","article-title":"Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00528","article-title":"Expansion of CD25-negative Forkhead Box P3-positive T cells during HIV and Mycobacterium tuberculosis infection","volume":"8","author":"Angerami","year":"2017","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/83707","article-title":"X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy","volume":"27","author":"Wildin","year":"2001","journal-title":"Nat Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Sci (New York NY)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.01.016","article-title":"Regulatory T cell lineage specification by the forkhead transcription factor foxp3","volume":"22","author":"Fontenot","year":"2005","journal-title":"Immunity"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/86302","article-title":"Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide","volume":"2","author":"Jordan","year":"2001","journal-title":"Nat Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.1.188","article-title":"Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen","volume":"167","author":"Thorstenson","year":"2001","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.celrep.2018.10.002","article-title":"Differential roles of IL-2 signaling in developing versus mature Tregs","volume":"25","author":"Fan","year":"2018","journal-title":"Cell Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3408","article-title":"Classical dendritic cells are required for dietary antigen-mediated induction of peripheral T(reg) cells and tolerance","volume":"17","author":"Esterh\u00e1zy","year":"2016","journal-title":"Nat Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030422","article-title":"Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells","volume":"198","author":"Yamazaki","year":"2003","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.immuni.2018.07.015","article-title":"Regulatory T cells promote macrophage efferocytosis during inflammation resolution","volume":"49","author":"Proto","year":"2018","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of IL-10(+) and IL-35(+) T(reg) cells cooperatively promotes tumor T cell exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nat Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e152511","DOI":"10.1172\/jci.insight.152511","article-title":"IL-35 promotes CD4+Foxp3+ Tregs and inhibits atherosclerosis via maintaining CCR5-amplified Treg-suppressive mechanisms","volume":"6","author":"Shao","year":"2021","journal-title":"JCI Insight"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1331609","article-title":"Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets","volume":"15","author":"Xia","year":"2024","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201800063","article-title":"TGF-\u03b2 control of adaptive immune tolerance: A break from Treg cells","volume":"40","author":"Liu","year":"2018","journal-title":"BioEssays: News Rev Molecular Cell Dev Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646710","article-title":"The IL-10\/STAT3 axis: Contributions to immune tolerance by thymus and peripherally derived regulatory T-cells","volume":"47","author":"Schmetterer","year":"2017","journal-title":"Eur J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402898","article-title":"IL-10 potentiates differentiation of human induced regulatory T cells via STAT3 and Foxo1","volume":"195","author":"Hsu","year":"2015","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.13044","article-title":"Interleukin-35 in immune-related diseases: Protection or destruction","volume":"157","author":"Zhang","year":"2019","journal-title":"Immunology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0046-y","article-title":"Biology and regulation of IL-2: From molecular mechanisms to human therapy","volume":"18","author":"Spolski","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.10.003","article-title":"Interleukin-2: Biology, design and application","volume":"36","author":"Arenas-Ramirez","year":"2015","journal-title":"Trends Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153682","article-title":"Inhibition of the JAK\/STAT signaling pathway in regulatory T cells reveals a very dynamic regulation of Foxp3 expression","volume":"11","author":"Goldstein","year":"2016","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903940","article-title":"Cutting edge: Mechanisms of IL-2-dependent maintenance of functional regulatory T cells","volume":"185","author":"Barron","year":"2010","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tips.2019.11.003","article-title":"Preserving the CTLA-4 checkpoint for safer and more effective cancer immunotherapy","volume":"41","author":"Liu","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e2023739118","DOI":"10.4049\/jimmunol.206.supp.96.04","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"PNAS"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.169","article-title":"Regulatory T cells in cardiovascular diseases","volume":"13","author":"Meng","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: A molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Sci (New York NY)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-022-01322-3","article-title":"Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: Implications for antitumor immunity","volume":"15","author":"Yan","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1172\/jci92079","article-title":"Tregs restrain dendritic cell autophagy to ameliorate autoimmunity","volume":"127","author":"Alissafi","year":"2017","journal-title":"J Clin Invest"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/a:1014256417651","article-title":"CD28 function: A balance of costimulatory and regulatory signals","volume":"22","author":"Bour-Jordan","year":"2002","journal-title":"J ClinImmunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201040712","article-title":"CD28 costimulation regulates FOXP3 in a RelA\/NF-\u03baB-dependent mechanism","volume":"41","author":"Soligo","year":"2011","journal-title":"Eur J Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.042564","article-title":"Superagonistic anti-CD28 antibodies: Potent activators of regulatory T cells for the therapy of autoimmune diseases","author":"Beyersdorf","year":"2005","journal-title":"Ann Rheumatic Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13755","article-title":"PD-1: A critical player and target for immune normalization","volume":"172","author":"Liu","year":"2024","journal-title":"Immunology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401936","article-title":"PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells","volume":"194","author":"Park","year":"2015","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J Exp Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.04.043","article-title":"Regulatory T cells increase after treatment with poly (ADP-ribose) polymerase-1 inhibitor in ischemic stroke patients","volume":"60","author":"Noh","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-14-0018","article-title":"Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity","volume":"3","author":"Bastid","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J Exp Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12951-021-01022-z","article-title":"Extracellular vesicles derived from CD73 modified human umbilical cord mesenchymal stem cells ameliorate inflammation after spinal cord injury","volume":"19","author":"Zhai","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2019.4349","article-title":"Overexpressed CD39 mitigates sepsis-induced kidney epithelial cell injury via suppressing the activation of NLR family pyrin domain containing 3","volume":"44","author":"Yang","year":"2019","journal-title":"Int J Mol Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.9.5916","article-title":"Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II","volume":"180","author":"Liang","year":"2008","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1016\/j.immuni.2024.08.008","article-title":"Inhibitory co-receptor Lag3 supports Foxp3(+) regulatory T cell function by restraining Myc-dependent metabolic programming","volume":"57","author":"Kim","year":"2024","journal-title":"Immunity"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2001188","article-title":"Lymphocyte activation gene-3 regulates dendritic cell metabolic programing and T cell priming function","volume":"207","author":"Garcia Cruz","year":"2021","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s10020-024-01014-3","article-title":"HFD aggravated the arthritis and atherosclerosis by altering the intestinal status and gut microbiota","volume":"30","author":"Shi","year":"2024","journal-title":"Mol Med (Cambridge Mass)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.934294","article-title":"Metagenomic and metabolomic analyses show correlations between intestinal microbiome diversity and microbiome metabolites in ob\/ob and ApoE(-\/-) mice","volume":"9","author":"Dong","year":"2022","journal-title":"Front Nutr"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00535-016-1242-9","article-title":"Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases","volume":"52","author":"Sun","year":"2017","journal-title":"J Gastroenterol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646768","article-title":"The inflammatory cytokine interferon-gamma inhibits sortilin-1 expression in hepatocytes via the JAK\/STAT pathway","volume":"47","author":"Pirault","year":"2017","journal-title":"Eur J Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.119.316461","article-title":"Regulatory T cells license macrophage pro-resolving functions during atherosclerosis regression","volume":"127","author":"Sharma","year":"2020","journal-title":"Circ Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.4.1783","article-title":"Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism","volume":"174","author":"Gondek","year":"2005","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.119.042863","article-title":"Pathogenic autoimmunity in atherosclerosis evolves from initially protective apolipoprotein B(100)-reactive CD4(+) T-regulatory cells","volume":"142","author":"Wolf","year":"2020","journal-title":"Circulation"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13537","article-title":"Th17\/Treg imbalance modulates rat myocardial fibrosis and heart failure by regulating LOX expression","volume":"230","author":"Lu","year":"2020","journal-title":"Acta Physiologica (Oxford England)"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8821029","article-title":"Th17\/Treg imbalance and atherosclerosis","volume":"2020","author":"He","year":"2020","journal-title":"Dis Markers"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2010.08.013","article-title":"The Th17\/Treg imbalance exists in patients with heart failure with normal ejection fraction and heart failure with reduced ejection fraction","volume":"411","author":"Li","year":"2010","journal-title":"Clinica Chimica Acta; Int J Clin Chem"},{"key":"B71","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2310\/jim.0000000000000023","article-title":"A shift in the balance of regulatory T and T helper 17 cells in rheumatic heart disease","volume":"62","author":"Bas","year":"2014","journal-title":"J Invest Medicine: Off Publ Am Fed For Clin Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"16171","DOI":"10.20452\/pamw.16171","article-title":"Th17\/Treg imbalance in patients with primary hyperaldosteronism and resistant hypertension","volume":"132","author":"Imiela","year":"2022","journal-title":"Polish Arch Internal Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"Ait-Oufella","year":"2006","journal-title":"Nat Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000089083.61317.a1","article-title":"Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice","volume":"108","author":"Mallat","year":"2003","journal-title":"Circulation"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.03.026","article-title":"Regulatory T cells prevent plaque disruption in apolipoprotein E-knockout mice","volume":"168","author":"Meng","year":"2013","journal-title":"Int J Cardiol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.03.016","article-title":"Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques","volume":"222","author":"George","year":"2012","journal-title":"Atherosclerosis"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl222","article-title":"Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes","volume":"27","author":"Mor","year":"2006","journal-title":"Eur Heart J"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.85.8.e17","article-title":"Protective role of interleukin-10 in atherosclerosis","volume":"85","author":"Mallat","year":"1999","journal-title":"Circ Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.2174\/1381612820666141014123810","article-title":"Novel anti-inflammatory interleukin-35 as an emerging target for antiatherosclerotic therapy","volume":"21","author":"Bobryshev","year":"2015","journal-title":"Curr Pharm Des"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2021.01.006","article-title":"B cells in atherosclerosis: mechanisms and potential clinical applications","volume":"6","author":"Pattarabanjird","year":"2021","journal-title":"JACC Basic to Trans Sci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.7.4180","article-title":"Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells","volume":"175","author":"Lim","year":"2005","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202502838","article-title":"CD74 blockade disrupts endothelial migrasome signaling to prevent inflammatory macrophage differentiation and inhibit atherosclerotic progression","volume":"12","author":"Zhang","year":"2025","journal-title":"Advanced Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70439","article-title":"Infusion of induced regulatory T cells alleviates atherosclerosis by reducing pathological macrophage-like vascular smooth muscle cells","volume":"6","author":"Zhang","year":"2025","journal-title":"MedComm"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1444533","article-title":"Epigenetic regulation of human FOXP3+ Tregs: from homeostasis maintenance to pathogen defense","volume":"15","author":"Yue","year":"2024","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.116.309764","article-title":"Atherosclerosis-driven Treg plasticity results in formation of a dysfunctional subset of plastic IFN\u03b3+ Th1\/Tregs","volume":"119","author":"Butcher","year":"2016","journal-title":"Circ Res"},{"key":"B86","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/eji.201948131","article-title":"Treg cell therapy: How cell heterogeneity can make the difference","volume":"51","author":"Giganti","year":"2021","journal-title":"Eur J Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/hjh.0000000000000761","article-title":"Deficiency of T-regulatory cells exaggerates angiotensin II-induced microvascular injury by enhancing immune responses","volume":"34","author":"Mian","year":"2016","journal-title":"J Hypertens"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00096.2019","article-title":"Role of T-cell activation in salt-sensitive hypertension","volume":"316","author":"Ren","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00792.2018","article-title":"Menopause and FOXP3(+) Treg cell depletion eliminate female protection against T cell-mediated angiotensin II hypertension","volume":"317","author":"Pollow","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3390\/antiox10101561","article-title":"Dieckol reduces muscle atrophy by modulating angiotensin type II type 1 receptor and NADPH oxidase in spontaneously hypertensive rats","volume":"10","author":"Oh","year":"2021","journal-title":"Antioxidants (Basel Switzerland)"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2014.12.003","article-title":"Role of T lymphocytes in hypertension","volume":"21","author":"Zhang","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.108.832782","article-title":"Regulatory T cells ameliorate angiotensin II-induced cardiac damage","volume":"119","author":"Kvakan","year":"2009","journal-title":"Circulation"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000784","article-title":"T-regulatory cells and vascular function: the importance of their immunosuppressive action in hypertensive disease","volume":"34","author":"Gal\u00e1n","year":"2016","journal-title":"J Hypertens"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.13181\/mji.rev.247521","article-title":"Role of regulatory T cells and T helper 17 cells in the pathogenesis of hypertension: a review","volume":"33","author":"Muliawan","year":"2025","journal-title":"Med J Indonesia"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-016-1414-3","article-title":"Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17\/Treg immune response","volume":"94","author":"Yan","year":"2016","journal-title":"J Mol Med (Berlin Germany)"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.125.073836","article-title":"Single-cell multi-omics identifies specialized cytotoxic and migratory CD8(+) effector T cells in acute myocarditis","volume":"152","author":"Tong","year":"2025","journal-title":"Circulation"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.112.267443","article-title":"MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis","volume":"111","author":"Corsten","year":"2012","journal-title":"Circ Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3390\/ijms24021752","article-title":"Treg therapy for the induction of immune tolerance in transplantation-not lost in translation","volume":"24","author":"Pilat","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/immadv\/ltad007","article-title":"Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective","volume":"3","author":"Sakaguchi","year":"2023","journal-title":"Immunotherapy Adv"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000003617","article-title":"Ex vivo expanded donor alloreactive regulatory T cells lose immunoregulatory, proliferation, and antiapoptotic markers after infusion into ATG-lymphodepleted, nonhuman primate heart allograft recipients","volume":"105","author":"Ezzelarab","year":"2021","journal-title":"Transplantation"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000229473.95202.50","article-title":"Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients","volume":"82","author":"Segundo","year":"2006","journal-title":"Transplantation"},{"key":"B102","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.3390\/ijms26093968","article-title":"Tolerogenic therapies in cardiac transplantation","volume":"26","author":"Wolner","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B103","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/jcdd10070310","article-title":"Blood immune cell alterations in patients with hypertensive left ventricular hypertrophy and heart failure with preserved ejection fraction","volume":"10","author":"Ovchinnikov","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.116.003688","article-title":"Activated T lymphocytes are essential drivers of pathological remodeling in ischemic heart failure","volume":"10","author":"Bansal","year":"2017","journal-title":"Circ Heart Failure"},{"key":"B105","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12872-023-03109-x","article-title":"Reduced numbers of regulatory T cells in chronic heart failure seems not to be restored by cardiac resynchronization therapy","volume":"23","author":"Martins","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s331320","article-title":"\u03b2-Hydroxybutyrate mitigated heart failure with preserved ejection fraction by increasing Treg cells via Nox2\/GSK-3\u03b2","volume":"14","author":"Liao","year":"2021","journal-title":"J Inflammation Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-014-0734-4","article-title":"Catechin ameliorates cardiac dysfunction in rats with chronic heart failure by regulating the balance between Th17 and Treg cells","volume":"63","author":"Zhang","year":"2014","journal-title":"Inflammation Research: Off J Eur Histamine Res Soc [et al]"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjtm.2016.05.006","article-title":"Study on the effect and mechanism of the dysfunction of CD4(+) T cells in the disease process of chronic cardiac failure","volume":"9","author":"Cai","year":"2016","journal-title":"Asian Pacific J Trop Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"12887","DOI":"10.1038\/s41598-019-49332-5","article-title":"Increased frequency of CD4(+)CD57(+) senescent T cells in patients with newly diagnosed acute heart failure: exploring new pathogenic mechanisms with clinical relevance","volume":"9","author":"Youn","year":"2019","journal-title":"Sci Rep"},{"key":"B110","doi-asserted-by":"publisher","first-page":"7806","DOI":"10.1007\/978-981-15-5305-9_27","article-title":"CD4(+) T cell subsets and PTPN22 as novel biomarkers of immune dysregulation in dilated cardiomyopathy","volume":"26","author":"Zhang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.118.036065","article-title":"Dysfunctional and proinflammatory regulatory T-lymphocytes are essential for adverse cardiac remodeling in ischemic cardiomyopathy","volume":"139","author":"Bansal","year":"2019","journal-title":"Circulation"},{"key":"B112","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41590-018-0051-0","article-title":"Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR","volume":"19","author":"Zemmour","year":"2018","journal-title":"Nat Immunol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.immuni.2019.01.001","article-title":"Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation","volume":"50","author":"Miragaia","year":"2019","journal-title":"Immunity"},{"key":"B114","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1560578","article-title":"The dual role of tissue regulatory T cells in tissue repair: return to homeostasis or fibrosis","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3085","article-title":"The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue\u2013resident regulatory T cells","volume":"16","author":"Vasanthakumar","year":"2015","journal-title":"Nat Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.it.2016.11.004","article-title":"Transcriptional regulation of tissue-resident lymphocytes","volume":"38","author":"Mackay","year":"2017","journal-title":"Trends Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1605849113","article-title":"Peripheral tolerance can be modified by altering KLF2-regulated Treg migration","volume":"113","author":"Pabbisetty","year":"2016","journal-title":"PNAS"},{"key":"B119","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/intimm\/dxu079","article-title":"CCR4 and its ligands: from bench to bedside","volume":"27","author":"Yoshie","year":"2014","journal-title":"Int Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155266","article-title":"Cytokines in the generation and function of regulatory T cell subsets in leishmaniasis","volume":"147","author":"Ghosh","year":"2021","journal-title":"Cytokine"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-021-00390-x","article-title":"The aryl hydrocarbon receptor regulates expression of mucosal trafficking receptor GPR15","volume":"14","author":"Swaminathan","year":"2021","journal-title":"Mucosal Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076331","article-title":"The role of LFA-1 for the differentiation and function of regulatory T cells\u2014lessons learned from different transgenic mouse models","volume":"24","author":"Klaus","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.603148","article-title":"Mucin-like domain of mucosal addressin cell adhesion molecule-1 facilitates integrin \u03b14\u03b27-mediated cell adhesion through electrostatic repulsion","volume":"8","author":"Yuan","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000970","article-title":"Layilin anchors regulatory T cells in skin","volume":"207","author":"Mehta","year":"2021","journal-title":"J Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.07.016","article-title":"Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics","volume":"57","author":"Raeber","year":"2024","journal-title":"Immunity"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.120.046789","article-title":"A unique population of regulatory T cells in heart potentiates cardiac protection from myocardial infarction","volume":"142","author":"Xia","year":"2020","journal-title":"Circulation"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.584048","article-title":"Foxp3+ regulatory T cells inhibit CCl4-induced liver inflammation and fibrosis by regulating tissue cellular immunity","volume":"11","author":"Ikeno","year":"2020","journal-title":"Front Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1440918","article-title":"Tff1-expressing Tregs in lung prevent exacerbation of bleomycin-induced pulmonary fibrosis","volume":"15","author":"Okamoto","year":"2024","journal-title":"Front Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.01.009","article-title":"Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis","volume":"57","author":"Savage","year":"2024","journal-title":"Immunity"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201103-0516oc","article-title":"Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis","volume":"184","author":"Lo Re","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00945-7","article-title":"Allies or enemies? The effect of regulatory T cells and related T lymphocytes on the profibrotic environment in bleomycin-injured lung mouse models","volume":"23","author":"Seyran","year":"2023","journal-title":"Clin Exp Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2012.05.020","article-title":"Differential role of regulatory T cells in early and late stages of pulmonary fibrosis","volume":"218","author":"Boveda-Ruiz","year":"2013","journal-title":"Immunobiology"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2009.05.007","article-title":"Plasticity of CD4(+) foxP3(+) T cells","volume":"21","author":"Zhou","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.01.070","article-title":"Blimp1 prevents methylation of Foxp3 and loss of regulatory T cell identity at sites of inflammation","volume":"26","author":"Garg","year":"2019","journal-title":"Cell Rep"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000002875","article-title":"Regulatory T cells and cardiovascular diseases","volume":"136","author":"Hu","year":"2023","journal-title":"Chin Med J"},{"key":"B138","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3390\/cells9122665","article-title":"Regulatory T cell stability and plasticity in atherosclerosis","volume":"9","author":"Ali","year":"2020","journal-title":"Cells"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116359","article-title":"Dysfunctional regulatory T cell: may be an obstacle to immunotherapy in cardiovascular diseases","volume":"173","author":"Zhang","year":"2024","journal-title":"Biomedicine Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-183251","article-title":"IL-17-producing human peripheral regulatory T cells retain suppressive function","volume":"113","author":"Beriou","year":"2009","journal-title":"Blood"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.12.002","article-title":"Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases","volume":"140","author":"Hovhannisyan","year":"2011","journal-title":"Gastroenterology"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204228","article-title":"Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood","volume":"74","author":"Wang","year":"2015","journal-title":"Ann Rheumatic Dis"},{"key":"B143","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12026-024-09586-2","article-title":"Dual neutralization of TGF-\u03b2 and IL-21 regulates Th17\/Treg balance by suppressing inflammatory signalling in the splenic lymphocytes of Staphylococcus aureus infection-induced septic arthritic mice","volume":"73","author":"Pramanik","year":"2025","journal-title":"Immunol Res"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01036-7","article-title":"Intricacies of TGF-\u03b2 signaling in Treg and Th17 cell biology","volume":"20","author":"Wang","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122665","article-title":"Regulatory T cell stability and plasticity in atherosclerosis","volume":"9","author":"Ali","year":"2020","journal-title":"Cells"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.03.044","article-title":"Hypoxia but not inflammation augments glucose uptake in human macrophages: implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography","volume":"58","author":"Folco","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/imr.12132","article-title":"Exploiting the curative potential of adoptive T-cell therapy for cancer","volume":"257","author":"Hinrichs","year":"2014","journal-title":"Immunol Rev"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/nri1710","article-title":"Fuel feeds function: energy metabolism and the T-cell response","volume":"5","author":"Fox","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(02)00323-0","article-title":"The CD28 signaling pathway regulates glucose metabolism","volume":"16","author":"Frauwirth","year":"2002","journal-title":"Immunity"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.7.4476","article-title":"Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways","volume":"180","author":"Jacobs","year":"2008","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110278","article-title":"HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells","volume":"208","author":"Shi","year":"2011","journal-title":"J Exp Med"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1159\/000362963","article-title":"Ox-LDL influences peripheral Th17\/Treg balance by modulating Treg apoptosis and Th17 proliferation in atherosclerotic cerebral infarction","volume":"33","author":"Li","year":"2014","journal-title":"Cell Physiol Biochemistry: Int J Exp Cell Physiology Biochemistry Pharmacol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"D\u00fcvel","year":"2010","journal-title":"Mol Cell"},{"key":"B155","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev-immunol-020711-075024","article-title":"Regulation of immune responses by mTOR","volume":"30","author":"Powell","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(02)00323-0","article-title":"The CD28 signaling pathway regulates glucose metabolism","volume":"16","author":"Frauwirth","year":"2002","journal-title":"Immunity"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.07.008","article-title":"Revving the engine: signal transduction fuels T cell activation","volume":"27","author":"Jones","year":"2007","journal-title":"Immunity"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the Rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat Cell Biol"},{"key":"B160","article-title":"The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1","volume-title":"Science","author":"Sancak","year":"2008"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2672","article-title":"Molecular mechanisms of mTOR-mediated translational control","volume":"10","author":"Ma","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e08-12-1248","article-title":"Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy","volume":"20","author":"Hosokawa","year":"2009","journal-title":"Mol Biol Cell"},{"key":"B163","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat Immunol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2012.08.019","article-title":"AMP-activated protein kinase: a target for drugs both ancient and modern","volume":"19","author":"Hardie","year":"2012","journal-title":"Chem Biol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.4161\/auto.7.6.15123","article-title":"The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR","volume":"7","author":"Egan","year":"2011","journal-title":"Autophagy"},{"key":"B167","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1042\/bj20120546","article-title":"AMP-activated protein kinase: new regulation, new roles","volume":"445","author":"Carling","year":"2012","journal-title":"Biochem J"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J Immunol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/nature08097","article-title":"Enhancing CD8 T-cell memory by modulating fatty acid metabolism","volume":"460","author":"Pearce","year":"2009","journal-title":"Nature"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-3932","article-title":"Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells","volume":"105","author":"Battaglia","year":"2005","journal-title":"Blood"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2008.07.022","article-title":"Bz-423 superoxide signals apoptosis via selective activation of JNK, Bak, and Bax","volume":"45","author":"Blatt","year":"2008","journal-title":"Free Radical Biol Med"},{"key":"B172","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cell.2008.04.052","article-title":"LXR signaling couples sterol metabolism to proliferation in the acquired immune response","volume":"134","author":"Bensinger","year":"2008","journal-title":"Cell"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/nature17412","article-title":"Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism","volume":"531","author":"Yang","year":"2016","journal-title":"Nature"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2, 3-dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells","volume":"176","author":"Fallarino","year":"2006","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103049","article-title":"The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis","volume":"138","author":"Huang","year":"2023","journal-title":"J Autoimmun"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2008213117","article-title":"Identification of a brainstem locus that inhibits tumor necrosis factor","volume":"117","author":"Kressel","year":"2020","journal-title":"PNAS"},{"key":"B179","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.1209985","article-title":"Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit","volume":"334","author":"Rosas-Ballina","year":"2011","journal-title":"Sci (New York NY)"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201243005","article-title":"Beta2-adrenergic receptor signaling in CD4+ Foxp3+ regulatory T cells enhances their suppressive function in a PKA-dependent manner","volume":"43","author":"Guereschi","year":"2013","journal-title":"Eur J Immunol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1158\/2326-6066.cir-17-0401","article-title":"\u03b2-adrenergic signaling impairs antitumor CD8(+) T-cell responses to B-cell lymphoma immunotherapy","volume":"6","author":"Nissen","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"B182","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5603\/aa.99713","article-title":"Immune crossroads in atherosclerosis: role of CD8+ T Cells, CD4+ T cells and toll-like receptors in lower extremity arterial disease","volume":"30","author":"Terpi\u0142owski","year":"2024","journal-title":"Acta Angiol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048614","article-title":"CD8(+) Tregs revisited: a heterogeneous population with different phenotypes and properties","volume":"51","author":"Niederlova","year":"2021","journal-title":"Eur J Immunol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.12.057","article-title":"CD8(+)CD25(+) T cells reduce atherosclerosis in apoE(-\/-) mice","volume":"443","author":"Zhou","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.114.010988","article-title":"Control of the T follicular helper-germinal center B-cell axis by CD8+ regulatory T cells limits atherosclerosis and tertiary lymphoid organ development","volume":"131","author":"Clement","year":"2015","journal-title":"Circulation"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2019.04.217","article-title":"CD39 identifies a microenvironment-specific anti-inflammatory CD8(+) T-cell population in atherosclerotic lesions","volume":"285","author":"van Duijn","year":"2019","journal-title":"Atherosclerosis"},{"key":"B187","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-9-S2-O5","article-title":"Immunosuppressive role of fibrinogen-like protein 2 (FGL2) in CD8+regulatory T cells-mediated long-term graft survival","volume":"9","author":"B\u00e9zie","year":"2011","journal-title":"J Transl Med"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaf098","article-title":"Targeting CD8+ T cells in cardiovascular diseases: current options and therapeutic perspectives","volume":"121","author":"Al-Rifai","year":"2025","journal-title":"Cardiovasc Res"},{"key":"B189","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41419-024-07086-7","article-title":"Epigenetic modification of CD4+ T cells into Tregs by 5-azacytidine as cellular therapeutic for atherosclerosis treatment","volume":"15","author":"Zhu","year":"2024","journal-title":"Cell Death Dis"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1166135","article-title":"Opportunities for Treg cell therapy for the treatment of human disease","volume":"14","author":"Bluestone","year":"2023","journal-title":"Front Immunol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00043","article-title":"Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity","volume":"10","author":"Romano","year":"2019","journal-title":"Front Immunol"},{"key":"B192","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/s12967-025-06561-9","article-title":"Clinical grade expansion protocol for the manufacture of thymus-derived Treg cells for clinical application","volume":"23","author":"Fanelli","year":"2025","journal-title":"J Transl Med"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1126761","article-title":"Targeting regulatory T cells for cardiovascular diseases","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.110.973222","article-title":"Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice","volume":"123","author":"Hermansson","year":"2011","journal-title":"Circulation"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adq3516","article-title":"Regulatory T cells attenuate chronic inflammation and cardiac fibrosis in hypertrophic cardiomyopathy","volume":"17","author":"Wang","year":"2025","journal-title":"Sci Transl Med"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113653","article-title":"Experimental myocardial infarction induces altered regulatory T cell hemostasis, and adoptive transfer attenuates subsequent remodeling","volume":"9","author":"Sharir","year":"2014","journal-title":"PloS One"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/s42003-025-08604-9","article-title":"Targeting VCAM-1 with chimeric antigen receptor and regulatory T cell for abdominal aortic aneurysm treatment","volume":"8","author":"Gang","year":"2025","journal-title":"Commun Biol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2024.110836","article-title":"Generation of immune cells from induced pluripotent stem cells (iPSCs): their potential for adoptive cell therapy","volume":"85","author":"Gheitasi","year":"2024","journal-title":"Hum Immunol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.stem.2024.05.004","article-title":"Human iPSC-derived CD4(+) Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft model","volume":"31","author":"Yano","year":"2024","journal-title":"Cell Stem Cell"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1093\/lifemedi\/lnaf002","article-title":"Pluripotent stem cell-based immunotherapy: advances in translational research, cell differentiation, and gene modifications","volume":"4","author":"Lei","year":"2025","journal-title":"Life Med"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1627149","article-title":"Clinical translation of human iPSC technologies: advances, safety concerns, and future directions","volume":"13","author":"Dhaiban","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2024.102069","article-title":"Therapy with regulatory T-cell infusion in autoimmune diseases and organ transplantation: a review of the strengths and limitations","volume":"85","author":"Alhosseini","year":"2024","journal-title":"Transplant Immunol"},{"key":"B203","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molimm.2024.06.003","article-title":"Regulatory T cells as a therapeutic target in acute myocardial infarction","volume":"172","author":"Wu","year":"2024","journal-title":"Mol Immunol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.2024.j116","article-title":"The potential of CAR-T cells for treating heart diseases: current status and hurdles in clinical translation","volume":"266","author":"Zhang","year":"2025","journal-title":"Tohoku J Exp Med"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.31083\/fbl41250","article-title":"Progress and future perspectives of Treg cell therapy","volume":"30","author":"Fang","year":"2025","journal-title":"Front Bioscience (Landmark Edition)"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxac105","article-title":"IL-2-based approaches to Treg enhancement","volume":"211","author":"Harris","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1056\/evidoa2100009","article-title":"Regulatory T-cell response to low-dose interleukin-2 in ischemic heart disease","volume":"1","author":"Zhao","year":"2022","journal-title":"NEJM Evidence"},{"key":"B208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.10.017","article-title":"A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease","volume":"95","author":"Peterson","year":"2018","journal-title":"J Autoimmun"},{"key":"B209","doi-asserted-by":"publisher","first-page":"eaba5264","DOI":"10.1126\/sciimmunol.aba5264","article-title":"An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice","volume":"5","author":"Khoryati","year":"2020","journal-title":"Sci Immunol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100103","article-title":"NKTR-358: a novel regulatory T-cell stimulator that selectively stimulates expansion and suppressive function of regulatory T cells for the treatment of autoimmune and inflammatory diseases","volume":"4","author":"Dixit","year":"2021","journal-title":"J Trans Autoimmun"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800907","article-title":"IL-2\/CD25: a long-acting fusion protein that promotes immune tolerance by selectively targeting the IL-2 receptor on regulatory T cells","volume":"201","author":"Ward","year":"2018","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01179-1","article-title":"Dynamic transcriptional activity and chromatin remodeling of regulatory T cells after varied duration of interleukin-2 receptor signaling","volume":"23","author":"Moro","year":"2022","journal-title":"Nat Immunol"},{"key":"B213","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3390\/diagnostics12061352","article-title":"Acute and chronic cardiopulmonary effects of high dose interleukin-2 therapy: an observational magnetic resonance imaging study","volume":"12","author":"Lagan","year":"2022","journal-title":"Diagnostics (Basel Switzerland)"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.120.315942","article-title":"Vaccination strategies and immune modulation of atherosclerosis","volume":"126","author":"Nilsson","year":"2020","journal-title":"Circ Res"},{"key":"B215","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-6445-1_1","article-title":"Overview of vaccine adjuvants: introduction, history, and current status","volume":"1494","author":"Shah","year":"2017","journal-title":"Methods Mol Biol (Clifton NJ)"},{"key":"B216","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2010_112","article-title":"Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues","volume":"354","author":"Czerkinsky","year":"2012","journal-title":"Curr Topics Microbiol Immunol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-307691","article-title":"Acute myocardial infarction and influenza: a meta-analysis of case-control studies","volume":"101","author":"Barnes","year":"2015","journal-title":"Heart (British Cardiac Society)"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-301743","article-title":"Pneumococcal vaccination and risk of acute coronary syndromes in patients with pneumonia: population-based cohort study","volume":"98","author":"Eurich","year":"2012","journal-title":"Heart (British Cardiac Society)"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.5114\/aoms\/133885","article-title":"PCSK9 immunization using nanoliposomes: preventive efficacy against hypercholesterolemia and atherosclerosis","volume":"17","author":"Momtazi-Borojeni","year":"2021","journal-title":"Arch Med Science: AMS"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2014.06.021","article-title":"FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activity","volume":"8","author":"Lehrer-Graiwer","year":"2015","journal-title":"JACC: Cardiovasc Imaging"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B223","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/circresaha.124.324999","article-title":"Autoimmune-like mechanism in heart failure enables preventive vaccine therapy","volume":"136","author":"Martini","year":"2025","journal-title":"Circ Res"},{"key":"B224","doi-asserted-by":"publisher","first-page":"394","DOI":"10.13201\/j.issn.1001-1439.2024.05.009","article-title":"The immunological effects and safety of HJY-ATRQ\u03b2-001 vaccine preparations with different proportions of aluminum adjuvant","volume":"40","author":"Hu","year":"2024","journal-title":"J Clin Cardiol"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.74141","article-title":"Innovative mRNA vaccine approaches in targeting atherosclerosis: a new era in cardiovascular therapy","volume":"16","author":"Kumar","year":"2024","journal-title":"Cureus"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2022.05.001","article-title":"Propionate alleviates abdominal aortic aneurysm by modulating colonic regulatory T-cell expansion and recirculation","volume":"7","author":"Yang","year":"2022","journal-title":"JACC Basic to Trans Sci"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.118.036652","article-title":"Short-chain fatty acid propionate protects from hypertensive cardiovascular damage","volume":"139","author":"Bartolomaeus","year":"2019","journal-title":"Circulation"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.765482","article-title":"Paeonol attenuated vascular fibrosis through regulating Treg\/Th17 balance in a gut microbiota-dependent manner","volume":"12","author":"Shi","year":"2021","journal-title":"Front Pharmacol"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110296","article-title":"Aspirin ameliorates atherosclerotic immuno-inflammation through regulating the Treg\/Th17 axis and CD39-CD73 adenosine signaling via remodeling the gut microbiota in ApoE(-\/-) mice","volume":"120","author":"Bai","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202100214","article-title":"The Lab4P consortium of probiotics attenuates atherosclerosis in LDL receptor deficient mice fed a high fat diet and causes plaque stabilization by inhibiting inflammation and several pro-atherogenic processes","volume":"65","author":"O'Morain","year":"2021","journal-title":"Mol Nutr Food Res"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.118.033714","article-title":"Bacteroides vulgatus and Bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis","volume":"138","author":"Yoshida","year":"2018","journal-title":"Circulation"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1690411","article-title":"Gut microbiota on cardiovascular diseases-a mini review on current evidence","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Microbiol"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.122.18558","article-title":"Short-chain fatty acid receptors and blood pressure regulation: Council on Hypertension Mid-Career Award for Research Excellence 2021","volume":"79","author":"Xu","year":"2022","journal-title":"Hypertension (Dallas Tex: 1979)"},{"key":"B234","volume-title":"StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Appaji Rayi declares no relevant financial relationships with ineligible companies","author":"Mandalaneni","year":""},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2020.1869384","article-title":"Vagus nerve plays a pivotal role in CD4+ T cell differentiation during CVB3-induced murine acute myocarditis","volume":"12","author":"Yue-Chun","year":"2021","journal-title":"Virulence"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1159\/000104853","article-title":"Stress system--organization, physiology and immunoregulation","volume":"13","author":"Elenkov","year":"2006","journal-title":"Neuroimmunomodulation"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00678-w","article-title":"Neuroimmune axis of cardiovascular control: mechanisms and therapeutic implications","volume":"19","author":"Carnevale","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.124.069420","article-title":"Suppression of the prostaglandin I2-type 1 interferon axis induces extramedullary hematopoiesis to promote cardiac repair after myocardial infarction","volume":"151","author":"Lv","year":"2025","journal-title":"Circulation"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102909","article-title":"miR-182\/183-Rasa1 axis induced macrophage polarization and redox regulation promotes repair after ischemic cardiac injury","volume":"67","author":"Yang","year":"2023","journal-title":"Redox Biol"},{"key":"B240","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-025-02220-z","article-title":"The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implications","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduction Targeted Ther"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.17-0040","article-title":"Cryopreserved off-the-shelf allogeneic adipose-derived stromal cells for therapy in patients with ischemic heart disease and heart failure-a safety study","volume":"6","author":"Kastrup","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"B242","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12967-019-2110-1","article-title":"Autologous adipose-derived stromal cell treatment for patients with refractory angina (MyStromalCell Trial): 3-years follow-up results","volume":"17","author":"Qayyum","year":"2019","journal-title":"J Transl Med"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5237063","article-title":"Adipose-derived stromal cells for treatment of patients with chronic ischemic heart disease (MyStromalCell Trial): a randomized placebo-controlled study","volume":"2017","author":"Qayyum","year":"2017","journal-title":"Stem Cells Int"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1080\/17460751.2025.2574194","article-title":"Results from the SCIENCE and Danish ASC trials using allogeneic mesenchymal stromal cells to treat ischemic heart failure patients","volume":"20","author":"Chaaban","year":"2025","journal-title":"Regenerative Med"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"B247","doi-asserted-by":"publisher","first-page":"8088","DOI":"10.3390\/ijms25158088","article-title":"IL-10 enhances the inhibitory effect of adipose-derived stromal cells on insulin resistance\/liver gluconeogenesis by Treg cell induction","volume":"25","author":"Lai","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B248","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3109\/10641955.2015.1032054","article-title":"IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia","volume":"34","author":"Harmon","year":"2015","journal-title":"Hypertension Pregnancy"},{"key":"B249","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cyto.2014.10.031","article-title":"Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy","volume":"74","author":"Saxena","year":"2015","journal-title":"Cytokine"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500020","article-title":"IL-33 reverses an obesity-induced deficit in visceral adipose tissue ST2+ T regulatory cells and ameliorates adipose tissue inflammation and insulin resistance","volume":"194","author":"Han","year":"2015","journal-title":"J Immunol"},{"key":"B251","doi-asserted-by":"publisher","first-page":"926","DOI":"10.21037\/atm-21-1952","article-title":"Tregs-derived interleukin 35 attenuates endothelial proliferation through STAT1 in pulmonary hypertension","volume":"9","author":"Wan","year":"2021","journal-title":"Ann Trans Med"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1159\/000493298","article-title":"Administration of interleukin-35-conditioned autologous tolerogenic dendritic cells prolong allograft survival after heart transplantation","volume":"49","author":"Liu","year":"2018","journal-title":"Cell Physiol Biochemistry: Int J Exp Cell Physiology Biochemistry Pharmacol"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107642","article-title":"Interleukin-35 regulates peripheral T cell activity in patients with Kawasaki disease","volume":"96","author":"Sun","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.900139","article-title":"Neuropilin-1 identifies a new subpopulation of TGF-\u03b2-induced Foxp3(+) regulatory T cells with potent suppressive function and enhanced stability during inflammation","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"B255","doi-asserted-by":"publisher","first-page":"17289","DOI":"10.1038\/s41598-017-17102-w","article-title":"Oestrogen receptor-\u03b1 binds the FOXP3 promoter and modulates regulatory T-cell function in human cervical cancer","volume":"7","author":"Adurthi","year":"2017","journal-title":"Sci Rep"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.4.2572","article-title":"Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: Implications for human reproduction","volume":"178","author":"Arruvito","year":"2007","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxl151","article-title":"Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1)","volume":"19","author":"Polanczyk","year":"2007","journal-title":"Int Immunol"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.4.2227","article-title":"Cutting edge: Estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment","volume":"173","author":"Polanczyk","year":"2004","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.14309\/00000434-200509001-00776","article-title":"Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease","volume":"103","author":"Kane","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"B260","doi-asserted-by":"publisher","first-page":"eaap9415","DOI":"10.1530\/ey.15.14.1","article-title":"Estrogen receptor \u03b1 contributes to T cell-mediated autoimmune inflammation by promoting T cell activation and proliferation","volume":"11","author":"Mohammad","year":"2018","journal-title":"Sci Signaling"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.5.668","article-title":"Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease","volume":"37","author":"Godet","year":"1995","journal-title":"Gut"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003919","article-title":"Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells","volume":"187","author":"Lee","year":"2011","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0426","article-title":"Progesterone increases systemic and local uterine proportions of CD4+CD25+ Treg cells during midterm pregnancy in mice","volume":"151","author":"Mao","year":"2010","journal-title":"Endocrinology"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E14-08-1323","article-title":"Androgen receptor modulates Foxp3 expression in CD4+CD25+Foxp3+ regulatory T-cells","volume":"26","author":"Walecki","year":"2015","journal-title":"Mol Biol Cell"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135858","article-title":"Metformin ameliorates inflammatory bowel disease by suppression of the STAT3 signaling pathway and regulation of the between Th17\/Treg balance","volume":"10","author":"Lee","year":"2015","journal-title":"PloS One"},{"key":"B266","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jneuroim.2016.01.014","article-title":"Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice","volume":"292","author":"Sun","year":"2016","journal-title":"J Neuroimmunology"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2010.03269.x","article-title":"Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-beta signal transduction","volume":"130","author":"Kim","year":"2010","journal-title":"Immunology"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.m010876","article-title":"Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis","volume":"52","author":"Tang","year":"2011","journal-title":"J Lipid Res"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803217","article-title":"1, 25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3","volume":"183","author":"Jeffery","year":"2009","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.06.099","article-title":"Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases","volume":"270","author":"Ntusi","year":"2018","journal-title":"Int J Cardiol"},{"key":"B271","doi-asserted-by":"publisher","first-page":"7526","DOI":"10.1038\/s41598-019-43899-9","article-title":"Th1, Th17, and Treg responses are differently modulated by TNF-\u03b1 inhibitors and methotrexate in psoriasis patients","volume":"9","author":"Furiati","year":"2019","journal-title":"Sci Rep"},{"key":"B272","doi-asserted-by":"publisher","first-page":"eaar8278","DOI":"10.1126\/scisignal.aar8278","article-title":"Aspirin ameliorates experimental autoimmune encephalomyelitis through interleukin-11-mediated protection of regulatory T cells","volume":"11","author":"Mondal","year":"2018","journal-title":"Sci Signaling"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1776040\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:19:10Z","timestamp":1774502350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1776040\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":272,"alternative-id":["10.3389\/fimmu.2026.1776040"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1776040","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"article-number":"1776040"}}